Mrs. Sharon Eileen Skujins, CADC II, NCAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 27678 Gretchen Ln, Pioneer, CA 95666 Phone: 209-295-1576 |
News Archive
A large clinical trial, known as the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-2), is set to take place, which aims to test monoclonal antibody efficacy and safety in people who have mild or moderate COVID-19.
For patients with sepsis, a serious infection causing widespread inflammation, immediate treatment is essential to improve the chances of survival. An updated "Hour-1 Bundle" of the international, evidence-based guidelines for treatment of sepsis is introduced in the June issue of Critical Care Medicine.
Researchers at the Charité - Universitätsmedizin Berlin have managed to predict the probability of a cardiovascular patient suffering a heart attack, stroke or arterial occlusion within three months.
Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions.
Today, the Hershey Center for Health and Nutrition joined with the American Dietetic Association to unveil Moderation Nation, a new national program which kicks off by providing complimentary visits with ADA member registered dietitians to consumers, age 18 or over. Moderation Nation seeks to educate people on how to achieve balance in their lives through moderation, both in nutrition and physical activity.
› Verified 5 days ago